In the U.S., false-positive mammograms cost $4 billion annually
New research has found that false-positive mammograms cost the U.S. $4 billion a year.
False-positives can occur because what looks like a tumor on an X-ray can actually be a cyst or a growth that later disappears. Mei-Sing Ong and Dr. Ken Mandl of Boston Children's Hospital studied false-positive mammograms and breast cancer overdiagnoses among more than 700,000 women between the ages of 40-59 from 2011 to 2013, NBC News reports.
They found that 77,729 women, or 11 percent of those screened, had a false-positive mammogram that caused them to have to get another mammogram, biopsy, or other test to determine if it was in fact breast cancer, at an average cost of $852 per person. "The costs associated with false-positive mammograms and breast cancer overdiagnoses appear to be much higher than previously documented," they wrote in the journal Health Affairs.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Political cartoons for November 8Cartoons Saturday’s political cartoons include narco boats, and the new Lincoln monument
-
Why Trump pardoned crypto criminal Changpeng ZhaoIn the Spotlight Binance founder’s tactical pardon shows recklessness is rewarded by the Trump White House
-
Sudoku medium: November 8, 2025The Week's daily medium sudoku puzzle
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
